All Effectiveness Bank analyses to date of documents related to use and problem use of illegal drugs starting with the analyses most recently added or updated, totalling today 813 documents.
Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
MATRIX CELL 2020 HTM file
Drug Treatment Matrix cell E4: Treatment systems; Psychosocial therapies
Seminal and key studies on local, regional and national systems for effectively and cost-effectively providing psychosocial therapies and the place of those therapies within these systems. Asks whether mutual aid groups can bridge the widening gap between resources and recovery ambitions, whether residential rehabilitation should be a last resort, and how tightly commissioners should specify services.
STUDY 2019 HTM file
ACT pill testing trial 2019: program evaluation
Olsen A., Wong G., McDonald D.
Australian National University, 2019
Independent evaluation suggests reasons to have confidence in the harm reduction benefits of ‘pill testing’. However, the narrow scope of the drug testing service adopted at this Australian festival may not have been adequately understood by stakeholders.
Levine H., Bartholomew T.S., Rea-Wilson V. et al.
Drug and Alcohol Dependence: 2019, 202, p. 13–17.
Did Florida’s first needle exchange programme result in fewer items of used injecting equipment being left in public places? The answer comes from a walkthrough of Miami neighbourhoods and interviews with people who inject drugs before and after the programme opened its doors.
Phillips C., Schulkind J., O’Sullivan M. et al.
Journal of Viral Hepatitis: 2020, 27, p. 176–187.
A UK-based project placed a dedicated full-time hepatitis C nurse into a drug and alcohol treatment service. The experiences of people who inject drugs and attended the service reveal the degree to which this strategy can remove barriers to the infection treatment so crucial to containing the virus.
Boyd J., Lavalley J., Czechaczek S. et al.
International Journal of Drug Policy: 2020, 78, p. 1–10.
[Consultation draft subject to amendment and correction.] ‘How can the design of drug consumption rooms be optimised to maximise their benefits?’ – a question that can be sidelined in the wider debate about the legitimacy of establishing consumption rooms in the first place. The featured study goes inside North America’s first women-only safer injecting facility to investigate the value of addressing gender-based discrimination and marginalisation inside a drug consumption room.
MATRIX CELL 2020 HTM file
Drug Treatment Matrix cell C4: Management/supervision; Psychosocial therapies
Seminal and key studies on management and supervision in psychosocial therapies. Findings challenge managers to invest in the post-training ‘coaching’ needed to make a difference for patients, and to set up systems alerting therapists to how well their clients are doing – especially when they are doing badly.
Evans E.A., Zhu Y., Yoo C. et al.
Addiction: 2019, 114, p. 1396–1404.
Can a limited period of being prescribed opiate-type medications generate longer term reductions in the criminal behaviour of patients dependent on illegal opiates like heroin? And of the two main medications – buprenorphine and methadone – which performs best? It seems a key factor is how well they retain patients in treatment.
Marino R., Landau A., Lynch M. et al.
Addiction: 2019, 114, p. 1575–1581.
Emergency department physicians regularly treat people who have had an opioid overdose, but they may not be making the most of the opportunity to provide take-home naloxone. Can a prompt in the patients’ electronic health records boost prescribing of this lifesaving ‘overdose antidote’?
MATRIX CELL 2020 HTM file
Drug Treatment Matrix cell E3: Treatment systems; Medical treatment
Seminal and key studies relating to local, regional and national systems for effectively and cost-effectively providing medical interventions and treatment in medical settings. Highlights a simple innovation which transformed detoxification recyclers into typical patients, asks if you agree with an expert group’s vision of what a good quality service looks like, and questions whether Britain is making progress on organising care for mentally ill problem drug users.
HOT TOPIC 2020 HTM file
Time for safer injecting spaces in Britain?
‘Hot topics’ offer background and analysis on important issues which sometimes generate heated debate. Drug consumption rooms are a particularly contentious form of harm reduction, viewed on one hand as a practical, humane, life-saving approach to dangerous drug use, and on the other, as an endorsement of drugtaking and a dereliction of the duty to treat people dependent on drugs.
Select search results pageNEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82